良性前列腺增生症的药物治疗进展

Advances in Drug Therapy of Benign Prostatic Hyperplasia

良性前列腺增生症是引起中老年男性排尿障碍最为常见的疾病,主要临床表现下尿路症状,严重影响患者生活质量。药物治疗是良性前列腺增生症治疗的一个重要部分,其安全性和有效性已得到广泛认可,主要包括5-α还原酶抑制剂、α受体阻滞剂、植物制剂及联合治疗。随着人们对药物治疗的探索及新型药物的出现,药物治疗成为轻中度患者的首选治疗方法。

Benign prostatic hyperplasia is the most common disease of middle-aged and old male population caused by urination dysfunction. The main clinical feature is lower urinary tract symptom, seriously affecting patients＇ quality of life. Drug treatment is important for benign prostatic hyperplasia and its safety and effectiveness has been widely recognized, mainly including 5-α reductase inhibitors, α-blockers, phytotherapy and combination therapy. Along with exploration for drug treatment and the emergence of new drugs, it has become the preferred treatment of mild-to-moderate patients.